Showing results (231-240 of 289) with videos related to

Sort By:
Pageof 29
Journal of Diabetes and Its Complications|April 22, 2026
Unveiling novel biomarkers for diabetes-related complications through large-scale proteomics analysis: A FIELD sub-studyHabib Francis, Andrzej S Januszewski, Matthew B O'Rourke, et al.
Ebiomedicine|July 20, 2026
Adjuvant aspirin for colorectal cancer with PIK3CA-mutated and COX-2 overexpressed tumours: the ASCOLT translational research study and meta-analysisEva Segelov, Shan Li, Isabel Li, et al.
Scientific Reports|January 25, 2022
VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancerFiona Chionh, Val Gebski, Sheren J Al-Obaidi, et al.
Gynecologic Oncology|June 12, 2025
No increase in chronic kidney disease after postoperative acute kidney injury in gynecologic oncologic ERAS surgerySarah P Huepenbecker, Maria D Iniesta, Mark F Munsell, et al.
The Lancet. Oncology|July 30, 2017
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trialEric Pujade-Lauraine, Jonathan A Ledermann, Frédéric Selle, et al.
The Lancet. Diabetes & Endocrinology|March 3, 2018
Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD studyBoris Waldman, Jean-Claude Ansquer, David R Sullivan, et al.
BMJ Open|September 3, 2021
Sertraline hydrochloride for reducing impulsive behaviour in male, repeat-violent offenders (ReINVEST): protocol for a phase IV, double-blind, placebo-controlled, randomised clinical trialTony Butler, Peter W Schofield, Lee Knight, et al.
The Lancet. Oncology|August 8, 2017
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trialsHarpreet S Wasan, Peter Gibbs, Navesh K Sharma, et al.
Eclinicalmedicine|December 16, 2025
Sertraline to reduce recidivism in impulsive violent offenders (ReINVEST): a randomised double blind clinical trialTony Butler, Emaediong I Akpanekpo, Lee Knight, et al.
Diabetes Research and Clinical Practice|February 23, 2026
Chronic complication risk and benefits of fenofibrate in type 2 diabetes by a PPARα polymorphism (rs6008845, C/T): a FIELD trial substudyAndrzej S Januszewski, Michael L H Huang, Abubakar Mangani, et al.
Pageof 29